Tevogen Bio Holdings Inc. (TVGNW)
USD 0.04
(3.96%)
USD 0.04
(3.96%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 2.27 Million | 953.08 Thousand | 4.61 Million |
| Selling, General and Administrative Expenses | 2.27 Million | 953.08 Thousand | 1.66 Million |
| Research and Development Expenses | - | 5.77 Million | 2.95 Million |
| Other Expenses | - | -7.38 Million | -10.37 Million |
| Cost and Expenses | 2.27 Million | 953.08 Thousand | 4.61 Million |
| Operating Income | -8843.03 | -13.72 Million | -4.61 Million |
| Interest Expense | 256.03 Thousand | - | 598.5 Thousand |
| Income Tax Expense | - | -230.82 Thousand | -9.78 Million |
| Earnings before Tax | -67.32 Thousand | 4.4 Million | -15.59 Million |
| Net Income | -67.32 Thousand | 4.4 Million | -15.59 Million |
| Earnings Per Share Basic | -0.00 | 0.04 | -0.13 |
| Earnings Per Share Diluted | -0.00 | 0.04 | -0.13 |
| Weighted Average Shares Outstanding | 165.42 Million | 119.99 Million | 119.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.42 Million | 119.99 Million | 119.99 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | 188.7 Thousand | -953.08 Thousand | -28.74 Thousand |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 99.99 Thousand | 98.3 Thousand | - | - | - | - |
| Gross Profit | -99.99 Thousand | -98.3 Thousand | - | - | - | - |
| Operating Expenses | 8.49 Million | 29.51 Million | 647.5 Thousand | 2.27 Million | 605.97 Thousand | 2.18 Million |
| Selling, General and Administrative Expenses | 4.37 Million | 8.7 Million | 647.5 Thousand | - | 605.97 Thousand | 1.15 Million |
| Research and Development Expenses | 4.12 Million | 20.81 Million | 908.04 Thousand | - | 1.11 Million | 1.03 Million |
| Other Expenses | -890 Thousand | 48.46 Million | - | - | - | -19.7 Million |
| Cost and Expenses | 8.59 Million | 29.51 Million | 647.5 Thousand | 2.27 Million | 605.97 Thousand | 2.18 Million |
| Operating Income | -8.59 Million | -29.51 Million | -647.51 Thousand | -2.27 Million | -605.97 Thousand | -2.18 Million |
| Interest Expense | 6.00 | 155.78 Thousand | 256.03 Thousand | 256.03 Thousand | - | 299.88 Thousand |
| Income Tax Expense | -3.61 Million | 48.62 Million | -44.09 Thousand | 255.86 Thousand | -39.73 Thousand | -19.38 Million |
| Earnings before Tax | -9.66 Million | 11.26 Million | -828.92 Thousand | -67.32 Thousand | -278.74 Thousand | -22.18 Million |
| Net Income | -6.05 Million | 11.26 Million | -828.92 Thousand | -67.32 Thousand | -278.74 Thousand | -22.18 Million |
| Earnings Per Share Basic | -0.04 | 0.08 | -0.06 | - | -0.02 | -1.40 |
| Earnings Per Share Diluted | -0.04 | -0.26 | -0.06 | - | -0.02 | -1.40 |
| Weighted Average Shares Outstanding | 154.16 Million | 137.33 Million | 14.93 Million | 165.42 Million | 15.81 Million | 15.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 154.16 Million | 142.38 Million | 14.93 Million | 165.42 Million | 15.81 Million | 15.81 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -8.49 Million | 19.05 Million | -647.51 Thousand | - | -605.97 Thousand | -21.88 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
AAATECH
SM
LMNR
CARBORUNIV
MOVE
6931